Maria Anzengruber
Overview
Explore the profile of Maria Anzengruber including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
12
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ratzinger-Stoeger G, Anzengruber M, Skoll K, Ertl D, Hartmann G, Gabor F
Eur J Hosp Pharm
. 2023 Dec;
32(2):161-165.
PMID: 38050051
Objectives: The aim of this project was to develop a rectal formulation of metyrapone suitable for application in an infant hospitalised with McCune-Albright syndrome (MAS)-related Cushing syndrome and to provide...
2.
Ertl D, Ratzinger-Stoeger G, Raimann A, Anzengruber M, Skoll K, Gabor F, et al.
Horm Res Paediatr
. 2023 Nov;
98(1):103-108.
PMID: 38008082
Introduction: Perinatal hypercorticism, regardless of its cause, has a high mortality or leads to life-long lasting complications. Some publications reported on the use of metyrapone in children with McCune Albright...
3.
Anzengruber M, Nepustil L, Kurtaj F, Tahir A, Skoll K, Sami H, et al.
Pharmaceutics
. 2023 May;
15(5).
PMID: 37242645
: Most frequently the functionalization of nanoparticles is hampered by time-consuming, sometimes harsh conjugation and purification procedures causing premature drug release and/or degradation. A strategy to circumvent multi-step protocols is...
4.
Skoll K, Palmetzhofer J, Lummerstorfer M, Anzengruber M, Gabor F, Wirth M
Nanomedicine
. 2023 Apr;
50:102685.
PMID: 37105340
Urinary tract infections (UTIs) are among the most common bacterial infections. Despite a wide range of therapeutic options, treatment success is compromised by the efficient mechanism of tissue colonization of...
5.
Mahr K, Anzengruber M, Hellerschmid A, Slezacek J, Hoi H, Subbiahdoss G, et al.
Gen Comp Endocrinol
. 2023 Feb;
336:114234.
PMID: 36791824
The administration of exogenous hormones emerged as an essential tool for field studies in endocrinology. However, working with wild animals remains challenging, because under field conditions not every available method...
6.
Anzengruber M, Wimmer L, Szuchar R, Skoll K, Wirth M, Gabor F
Eur J Pharm Sci
. 2022 Nov;
180:106330.
PMID: 36379358
After surgical removal of the tumour tissue, bladder cancer is treated by intravesical instillation of cytotoxic drugs such as gemcitabine. Gemcitabine, however, is highly hydrophilic and possesses a short half-life...